Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Drug patent watch trametinib?What's the recommended schedule for lurbinectedin side effect checks?When did risperdal constas patent expire published article?When will generic fiasap insulin be available?Dabrafenib btd date 2023?
See the DrugPatentWatch profile for rifampin
Rifampin can reduce tigecycline exposure by inducing drug-metabolizing enzymes and transporters. Because of this interaction, tigecycline’s recommended dosage changes when rifampin is given at the same time as tigecycline. The dosing adjustment is to reduce tigecycline to 25% of the usual dose during coadministration with rifampin.
During coadministration with rifampin, the usual tigecycline dose is reduced to one-quarter (25%). [1]
The key dosing change is tied to the presence of rifampin. The recommendation is based on rifampin’s ability to lower tigecycline concentrations, so clinicians apply the dosage reduction whenever tigecycline is used concurrently with rifampin. [1]
If rifampin is started or stopped while a patient is on tigecycline, the dosing recommendation is determined by whether rifampin and tigecycline are being coadministered at that time. That means the tigecycline dose should follow the 25% reduction during the period of coadministration. [1]
Other Questions About Rifampin :